Skip to content

COMPARATIVE STUDY OF EFECTS OF DEXMEDETOMIDINE VERSES PROPOFOL FOR SEDATION IN PAEDIATRIC AGE GROUP PATIENTS UNDERGOING MAGNETIC RESONANCE IMAGING

COMPARATIVE STUDY OF EFFICACY OF DEXMEDETOMIDINE VERSES PROPOFOL FOR SEDATION IN PAEDIATRIC AGE GROUP PATIENTS UNDERGOING MAGNETIC RESONANCE IMAGING- A PROSPECTIVE STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/07/044434
Enrollment
60
Registered
2022-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F99- Mental disorder, not otherwise specified Health Condition 2: G94- Other disorders of brain in diseases classified elsewhere

Interventions

Control Intervention1: comparison between dexmeditomidine and propofol: Dexmeditomidine by intravenous route. Dose-infusion @0.8mcg/kg over 10 mins, followed by continous infusion@0.4-0.6mcg/kg/hr Con

Sponsors

MGMCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: UNCOOPERATIVE CHILD FOR MRI HAVING ASA1 AND ASA2 GRADE

Exclusion criteria

Exclusion criteria: anticipated difficult intubation allergy to study drugs

Design outcomes

Primary

MeasureTime frame
ramsay sedation score safety of drugTimepoint: 2 hrs

Secondary

MeasureTime frame
observation in recovery roomTimepoint: 24 hrs

Countries

India

Contacts

Public ContactVISHAKHA TANWAR

MAHATMA GANDHI MEDICAL COLLEGE AND HOSPITAL

vishakhatanwar111@gmail.com8209685317

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026